Herbal medicine Dosage Major/active constituents Key evidence Potential AEs Potential clinical use Clinical advice Bitter orange (Citrus aurantium) Acute dose: 1 ml/kg of distillate; standardized for linalool, total phenolic acids,…
Herbal medicine Dosage Major/active constituents Key evidence Potential AEs Potential clinical use Clinical advice Kava (Piper methysticum) Total dose of 50–250 mg of kavalactonesper day, approximating 50–60 mg of kavalactones…
Herbal medicine Dosage Major/active constituents Key evidence Potential adverse effects Potential clinical use Clinical advice Brahmi (Bacopa monnieri) Acute: 320 mg or 640 mg of Brahmi extract Chronic: 300 mg/d…
© Springer International Publishing Switzerland 2017David Camfield, Erica McIntyre and Jerome Sarris (eds.)Evidence-Based Herbal and Nutritional Treatments for Anxiety in Psychiatric Disorders10.1007/978-3-319-42307-4_1 1. The Need for Evidence-Based Herbal and Nutritional Anxiety Treatments in Psychiatry David A. Camfield1, 2 ,…
Herbal medicine Dosage Major/active constituents Key evidence PotentialAEs Potentialclinical use Clinical advice Ashwagandha (Withania somnifera) Total dose of 500–1000 mg/day dried extract standardised to withanolides, or 4–6 g/day root powder…
Herbal medicine Dosage Major/Active Constituents Key evidence Potential AEs Potential clinical use Clinical advice Ayahuasca ( Psychotria viridis plus Banisteriopsis caapi; or B. caapi plus Diplopterys cabrerana) Variable dosage MAOI:…
Herbal medicine Dosage Mechanisms of action Key evidence Potential AEs Potential clinical use Clinical advice MV/B vitamins B9 > 800 μg B12 > 1 mg HCy lowering, HPA axis regulation…
Nutraceutical Dosage Major/active constituents Key evidence Potential AEs Potential clinical use Clinical advice St John’s wort (Hypericum perforatum) 1 mg of hypericin per day (one or two times per day);…
A. Event: Bereavement (loss of a significant other) from at least 6 months B. Separation distress: One (or more) of the following symptoms of persistent intense acute grief has been present for a…
Authors (year) Design Population Duration Time since loss Drug Results Bereavement-related depression Jacobs et al. [8] Open-label (ITT) n = 10, age range = 26–65, 80% women 4 weeks Desipramine, 75–150 mg/day Depressive symptoms: 70% responders…
